Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease

Inclusion criteria

• Adequate completion of informed consent process with written documentation
• Patients 18 - 65 years old
• • Physician diagnosis of muco-obstructive pulmonary disease, including cystic fibrosis, severe asthma, chronic obstructive pulmonary disease, or non-cystic fibrosis bronchiectasis for \> 1 year
• Able to perform reproducible spirometry according to ATS criteria based on clinical PFTs.

Exclusion criteria

• Respiratory tract infection within the 4 weeks prior to Visit 1
• Body mass index (BMI) \> 30 at Visit 1
• One-time doses such as intra-articular injections require a 4-week washout prior to Visit 1
• ER visit related to pulmonary condition within the previous 4 weeks of Visit 1
• Significant concomitant medical illness, including (but not limited to) heart disease, cancer, uncontrolled diabetes, other chronic lung diseases (determined by the Investigator.)
• Resting O2 saturation \<90% with maximum supplemental O2 delivered by nasal canula
• Positive urine pregnancy test
• Participation in an intervention study (including bronchoscopy) or use of investigative drugs within the past 30 days or plans to enroll in such a trial during the study
• Unable or unlikely to complete study assessments in the opinion of the Investigator
• Study intervention poses undue risk to patient in the opinion of the Investigator
• Conditions that will prohibit MRI scanning determined by the MRI safety screening.